Literature DB >> 30848283

Carotid Artery Stenting and Intracranial Thrombectomy for Tandem Cervical and Intracranial Artery Occlusions.

Byungjun Kim1, Byung Moon Kim2, Oh Young Bang3, Jang-Hyun Baek4, Ji Hoe Heo5, Hyo Suk Nam5, Young Dae Kim5, Joonsang Yoo6, Dong Joon Kim2, Pyoung Jeon7, Seung Kug Baik8, Sang Hyun Suh9, Kyung-Yul Lee10, Hyo Sung Kwak11, Hong Gee Roh12, Young-Jun Lee13, Sang Heum Kim14, Chang Woo Ryu15, Yon-Kwon Ihn16, Hong-Jun Jeon17, Jin Woo Kim18, Jun Soo Byun19, Sangil Suh20, Jeong Jin Park12, Woong Jae Lee19, Jieun Roh8, Byoung-Soo Shin21.   

Abstract

BACKGROUND: It remains controversial whether carotid artery stenting (CAS) is needed in cases of tandem cervical internal carotid artery occlusion (cICAO) and intracranial large vessel occlusion (LVO).
OBJECTIVE: To investigate the efficacy and safety of CAS in combination with endovascular thrombectomy (CAS-EVT) in cICAO-LVO patients and to compare its outcomes with those of EVT without CAS (EVT-alone).
METHODS: We identified all patients who underwent EVT for tandem cICAO-LVO from the prospectively maintained registries of 17 stroke centers. Patients were classified into 2 groups: CAS-EVT and EVT-alone. Clinical characteristics and procedural and clinical outcomes were compared between 2 groups. We tested whether CAS-EVT strategy was independently associated with recanalization success.
RESULTS: Of the 955 patients who underwent EVT, 75 patients (7.9%) had cICAO-LVO. Fifty-six patients underwent CAS-EVT (74.6%), and the remaining 19 patients underwent EVT-alone (25.4%). The recanalization (94.6% vs 63.2%, P = .002) and good outcome rates (64.3% vs 26.3%, P = .007) were significantly higher in the CAS-EVT than in the EVT-alone. Mortality was significantly lower in the CAS-EVT (7.1% vs 21.6%, P = .014). There was no significant difference in the rate of symptomatic intracranial hemorrhage between 2 groups (10.7 vs 15.8%; P = .684) and according to the use of glycoprotein IIb/IIIa inhibitor (10.0% vs 12.3%; P = .999) or antiplatelet medications (10.2% vs 18.8%; P = .392). CAS-EVT strategy remained independently associated with recanalization success (odds ratio: 24.844; 95% confidence interval: 1.445-427.187).
CONCLUSION: CAS-EVT strategy seemed to be effective and safe in cases of tandem cICAO-LVO. CAS-EVT strategy was associated with recanalization success, resulting in better clinical outcome.
Copyright © 2019 by the Congress of Neurological Surgeons.

Entities:  

Keywords:  Acute stroke; Carotid arteries; Stent; Thrombectomy

Mesh:

Substances:

Year:  2020        PMID: 30848283     DOI: 10.1093/neuros/nyz026

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  4 in total

1.  Acute Carotid Artery Stenting Versus Balloon Angioplasty for Tandem Occlusions: A Systematic Review and Meta-Analysis.

Authors:  Cynthia B Zevallos; Mudassir Farooqui; Darko Quispe-Orozco; Alan Mendez-Ruiz; Andres Dajles; Aayushi Garg; Milagros Galecio-Castillo; Mary Patterson; Osama Zaidat; Santiago Ortega-Gutierrez
Journal:  J Am Heart Assoc       Date:  2022-01-13       Impact factor: 6.106

2.  Efficacy and Safety of Endovascular Treatment in Acute Tandem Carotid Occlusions: Analysis of a Single-Center Cohort.

Authors:  Santiago Fernández Menéndez; Eduardo Murias Quintana; Pedro Vega Valdés; Edison Morales Deza; Elena López-Cancio; Lorena Benavente Fernández; Montserrat González Delgado; Maria Rico-Santos; Sergio Calleja Puerta; Davinia Larrosa Campo
Journal:  Cerebrovasc Dis Extra       Date:  2020-06-24

3.  Predictors of a Favorable Outcome after Emergent Carotid Artery Stenting in Acute Anterior Circulation Stroke Patients.

Authors:  Gyeong Il Moon; Byung Hyun Baek; Seul Kee Kim; Yun Young Lee; Hyo-Jae Lee; Woong Yoon
Journal:  Taehan Yongsang Uihakhoe Chi       Date:  2020-05-29

4.  Emergency Carotid Endarterectomy Instead of Carotid Artery Stenting Reduces Delayed Hemorrhage in Thrombectomy Stroke Patients.

Authors:  Raveena Singh; Sven Dekeyzer; Arno Reich; Drosos Kotelis; Alexander Gombert; Martin Wiesmann; Omid Nikoubashman
Journal:  Clin Neuroradiol       Date:  2020-09-17       Impact factor: 3.649

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.